Peer Review reports
From: Acetazolamide potentiates the anti-tumor potential of HDACi, MS-275, in neuroblastoma
| Original Submission | ||
|---|---|---|
| 15 Oct 2016 | Submitted | Original manuscript |
| 3 Nov 2016 | Reviewed | Reviewer Report - Ruchi Saxena |
| 7 Nov 2016 | Reviewed | Reviewer Report - Vikas Mishra |
| 5 Jan 2017 | Author responded | Author comments - Reza Bayat Mokhtari |
| Resubmission - Version 2 | ||
| 5 Jan 2017 | Submitted | Manuscript version 2 |
| 17 Jan 2017 | Author responded | Author comments - Reza Bayat Mokhtari |
| Resubmission - Version 3 | ||
| 17 Jan 2017 | Submitted | Manuscript version 3 |
| 3 Feb 2017 | Author responded | Author comments - Reza Bayat Mokhtari |
| Resubmission - Version 4 | ||
| 3 Feb 2017 | Submitted | Manuscript version 4 |
| Publishing | ||
| 8 Feb 2017 | Editorially accepted | |
| 24 Feb 2017 | Article published | 10.1186/s12885-017-3126-7 |
You can find further information about peer review here.